Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Most cells physiologically release vesicles as way of intercellular communication. The so-called Extracellular Vesicles (EVs) include exosomes, ectosomes, and apoptotic bodies, which basically differ in their composition and subcellular origin. Specifically, EVs found in urine reflect the state of the urinary system, from podocytes to renal-tubular cells, thus making them an excellent source of samples for the study of kidney physiology and pathology. Several groups have focused on defining biomarkers of kidney-related disorders, from graft rejection to metabolic syndromes. So far, the lack of a standard protocol for EVs isolation precludes the possibility of a proper comparison among the different biomarkers proposed in the literature, stressing the need for validation of these biomarkers not only in larger cohorts of patients but also considering the different methods for EVs isolation. In this review, we aim to gather the current knowledge about EVs-related biomarkers in kidney diseases, with a special emphasis in the methods used to date for EVs enrichment, and discussing the need for more specific protocols of EV isolation in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“In this sense, EVs contain a specific subset of common proteins related to biogenesis and trafficking and also a specific signature from their cell or tissue of origin (8, 11), including protein and nucleic acids (4, 12, 13).”
BackgroundBiogenesis and secretion of exosomes
Kowal, J., Tkach, M., & Théry, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.05.004 · Cited by 1,781
Shedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367
Self-citationEpidemiology of acute renal failure: A prospective, multicenter, community-based study
Liaño, F., Pascual, J., & The Madrid Acute Renal Failure Study Group (1996) · Kidney International · doi:10.1038/ki.1996.380 · Cited by 978
Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages
Lässer, C., Seyed Alikhani, V., Ekström, K., Eldh, M., Torregrosa Paredes, P., Bossios, A., Sjöstrand, M., Gabrielsson, S., Lötvall, J., & Valadi, H. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-9 · Cited by 899 · cited 1×
“These vesicles can be released from different kind of cells, from platelets to cells of the immune system and neurons, among others (4), and can be found in several body fluids, including plasma, urine, and saliva (5, 6).”
BackgroundLarge-scale proteomics and phosphoproteomics of urinary exosomes
Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D., Star, R. A., Kleta, R., Wang, N. S., & Knepper, M. A. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040406 · Cited by 727
Tamm-Horsfall protein and urinary exosome isolation
Fernández-Llama, P., Khositseth, S., Gonzales, P. A., Star, R. A., Pisitkun, T., & Knepper, M. A. (2010) · Kidney International · doi:10.1038/ki.2009.550 · Cited by 290 · cited 5×
“DTT-treatment has been the most widely solution to avoid EV-entrapment by THP (22).”
BackgroundInfluential
Research works printed but not linked: 79
- Mittelbrunn, 2011, Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, Nat Commun, 2, 282, 10.1038/ncomms1285 · DOI · Paper page
- Borges, 2013, Extracellular vesicles: structure, function, and potential clinical uses in renal diseases, Braz J Med Biol Res, 46, 824, 10.1590/1414-431X20132964 · DOI · Paper page
- Wang, 2014, Urinary extracellular microvesicles: isolation methods and prospects for urinary proteome, Proteomics, 14, 1922, 10.1002/pmic.201300371 · DOI · Paper page
- Witwer, 2013, Standardization of sample collection, isolation and analysis methods in extracellular vesicle research, J Extracell Vesicles, 2, 1, 10.3402/jev.v2i0.20360 · DOI · Paper page
- Mathivanan, 2010, Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature, Mol Cell Proteomics, 9, 197, 10.1074/mcp.M900152-MCP200 · DOI · Paper page
- Ohno, 2013, Roles of exosomes and microvesicles in disease pathogenesis, Adv Drug Deliv Rev, 65, 398, 10.1016/j.addr.2012.07.019 · DOI
- Wang, 2012, Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT), Proteomics, 12, 329, 10.1002/pmic.201100477 · DOI · Paper page
- Lázaro-Ibáñez, 2014, Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes, Prostate, 74, 1379, 10.1002/pros.22853 · DOI · Paper page
- Simpson, 2012, ExoCarta as a resource for exosomal research, J Extracell Vesicles, 1, 10.3402/jev.v1i0.18374 · DOI · Paper page
- Mathivanan, 2012, ExoCarta 2012: database of exosomal proteins, RNA and lipids, Nucleic Acids Res, 40, D1241, 10.1093/nar/gkr828 · DOI · Paper page
- Kim, 2014, EVpedia: a community web portal for extracellular vesicles research, Bioinformatics, 10.1093/bioinformatics/btu741 · DOI · Paper page
- Adachi, 2006, The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins, Genome Biol, 7, R80, 10.1186/gb-2006-7-9-R80 · DOI · Paper page
- Pisitkun, 2006, Discovery of urinary biomarkers, Mol Cell Proteomics, 5, 1760, 10.1074/mcp.R600004-MCP200 · DOI · Paper page
- Zhou, 2006, Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery, Kidney Int, 69, 1471, 10.1038/sj.ki.5000273 · DOI · Paper page
- Jacquillet, 2013, Urinary vesicles: in splendid isolation, Nephrol Dial Transplant, 28, 1332, 10.1093/ndt/gfs599 · DOI
- Rood, 2010, Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome, Kidney Int, 78, 810, 10.1038/ki.2010.262 · DOI · Paper page
- Musante, 2012, Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment, PLoS One, 7, e37279, 10.1371/journal.pone.0037279 · DOI · Paper page
- Salih, 2014, Urinary extracellular vesicles and the kidney: biomarkers and beyond, Am J Physiol Renal Physiol, 306, F1251, 10.1152/ajprenal.00128.2014 · DOI · Paper page
- Harding, 1983, Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing, Biochem Biophys Res Commun, 113, 650, 10.1016/0006-291X(83)91776-X · DOI · Paper page
- Johnstone, 1984, The fate of the transferrin receptor during maturation of sheep reticulocytes in vitro, Biochem Cell Biol, 62, 1246, 10.1139/o84-159 · DOI
- Raj, 2012, A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes, Kidney Int, 81, 1263, 10.1038/ki.2012.25 · DOI
- Yuana, 2014, Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation, J Extracell Vesicles, 3, 1, 10.3402/jev.v3.23262 · DOI · Paper page
- Van Deun, 2014, The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling, J Extracell Vesicles, 3, 24858, 10.3402/jevv3.24858 · doi:10.3402/jevv3.24858
- Cvjetkovic, 2014, The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles, J Extracell Vesicles, 3, 10.3402/jev.v3.23111 · DOI · Paper page
- Cheruvanky, 2007, Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator, Am J Physiol Renal Physiol, 292, F1657, 10.1152/ajprenal.00434.2006 · DOI · Paper page
- Merchant, 2010, Microfiltration isolation of human urinary exosomes for characterization by MS, Proteomics Clin Appl, 4, 84, 10.1002/prca.200800093 · DOI · Paper page
- Kalra, 2013, Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma, Proteomics, 13, 3354, 10.1002/pmic.201300282 · DOI · Paper page
- Ghosh, 2014, Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins, PLoS One, 9, e110443, 10.1371/journal.pone.0110443 · DOI · Paper page
- Schageman, 2013, The complete exosome workflow solution: from isolation to characterization of RNA cargo, Biomed Res Int, 2013, 253957, 10.1155/2013/253957 · DOI · Paper page
- Musante, 2014, Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy, Front Endocrinol, 5, 149, 10.3389/fendo.2014.00149 · DOI · Paper page
- Alvarez, 2012, Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers, Kidney Int, 82, 1024, 10.1038/ki.2012.256 · DOI · Paper page
- Muller, 2014, Isolation of biologically-active exosomes from human plasma, J Immunol Methods, 411, 55, 10.1016/j.jim.2014.06.007 · DOI · Paper page
- Böing, 2014, Single-step isolation of extracellular vesicles by size-exclusion chromatography, J Extracell Vesicles, 3, 23430, 10.3402/jev.v3.23430 · DOI · Paper page
- Kanwar, 2014, Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes, Lab Chip, 14, 1891, 10.1039/c4lc00136b · DOI · Paper page
- Santana, 2014, Microfluidic isolation of cancer-cell-derived microvesicles from hetergeneous extracellular shed vesicle populations, Biomed Microdevices, 16, 869, 10.1007/s10544-014-9891-z · DOI
- Channavajjhala, 2014, Optimizing the purification and analysis of miRNAs from urinary exosomes, Clin Chem Lab Med, 52, 345, 10.1515/cclm-2013-0562 · DOI
- Wolfe, 1999, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, 341, 1725, 10.1056/NEJM199912023412303 · DOI · Paper page
- Miranda, 2010, Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease, Kidney Int, 78, 191, 10.1038/ki.2010.106 · DOI · Paper page
- Hoorn, 2005, Prospects for urinary proteomics: exosomes as a source of urinary biomarkers, Nephrology (Carlton), 10, 283, 10.1111/j.1440-1797.2005.00387.x · DOI · Paper page
- Dear, 2013, Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling, Proteomics, 13, 1572, 10.1002/pmic.201200285 · DOI · Paper page
- Zhou, 2008, Urinary exosomal transcription factors, a new class of biomarkers for renal disease, Kidney Int, 74, 613, 10.1038/ki.2008.206 · DOI · Paper page
- Sonoda, 2009, Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury, Am J Physiol Renal Physiol, 297, F1006, 10.1152/ajprenal.00200.2009 · DOI
- Zhou, 2013, Urinary exosomal Wilms’ tumor-1 as a potential biomarker for podocyte injury, Am J Physiol Renal Physiol, 305, F553, 10.1152/ajprenal.00056.2013 · DOI
- Gutwein, 2010, ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases, J Biomed Sci, 17, 3, 10.1186/1423-0127-17-3 · doi:10.1186/1423-0127-17-3
- Barutta, 2013, Urinary exosomal microRNAs in incipient diabetic nephropathy, PLoS One, 8, e73798, 10.1371/journal.pone.0073798 · DOI · Paper page
- Sun, 2012, Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease, Diab Vasc Dis Res, 9, 301, 10.1177/1479164111434318 · DOI
- Zubiri, 2014, Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis, J Proteomics, 96, 92, 10.1016/j.jprot.2013.10.037 · DOI · Paper page
- Ichii, 2014, Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis, PLoS One, 9, e110383, 10.1371/journal.pone.0110383 · DOI
- Moon, 2011, Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy, Proteomics, 11, 2459, 10.1002/pmic.201000443 · DOI · Paper page
- Lv, 2013, MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis, Am J Physiol Renal Physiol, 305, F1220, 10.1152/ajprenal.00148.2013 · DOI · Paper page
- Lv, 2014, CD2AP mRNA in urinary exosome as biomarker of kidney disease, Clin Chim Acta, 428, 26, 10.1016/j.cca.2013.10.003 · DOI
- Peake, 2014, A comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation, PLoS One, 9, e98644, 10.1371/journal.pone.0098644 · DOI
- Alvarez, 2013, Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation, Transplant Proc, 45, 3719, 10.1016/j.transproceed.2013.08.079 · DOI
- Dimuccio, 2014, Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage, PLoS One, 9, e104490, 10.1371/journal.pone.0104490 · DOI
- Hogan, 2009, Characterization of PKD protein-positive exosome-like vesicles, J Am Soc Nephrol, 20, 278, 10.1681/ASN.2008060564 · DOI · Paper page
- Bijnsdorp, 2013, Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients, J Extracell Vesicles, 2, 22097, 10.3402/jev.v2i0.22097 · DOI · Paper page
- Corcoran, 2014, miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression: extracellular miRNAs as biomarkers for CRPC, Prostate, 74, 1320, 10.1002/pros.22848 · DOI · Paper page
- Mitchell, 2009, Can urinary exosomes act as treatment response markers in prostate cancer?, J Transl Med, 7, 4, 10.1186/1479-5876-7-4 · DOI · Paper page
- Beckham, 2014, Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression, J Urol, 192, 583, 10.1016/j.juro.2014.02.035 · DOI · Paper page
- Perez, 2014, A pilot study on the potential of RNA-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer, Cancers, 6, 179, 10.3390/cancers6010179 · DOI
- Chen, 2012, Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients, J Proteome Res, 11, 5611, 10.1021/pr3008732 · DOI · Paper page
- Raimondo, 2013, Differential protein profiling of renal cell carcinoma urinary exosomes, Mol Biosyst, 9, 1220, 10.1039/c3mb25582d · DOI · Paper page
- Lameire, 2005, Acute renal failure, Lancet, 365, 417, 10.1016/S0140-6736(05)17831-3 · doi:10.1016/s0140-6736(05)17831-3 · Paper page
- Barrera-Chimal, 2011, Hsp72 is an early and sensitive biomarker to detect acute kidney injury: Hsp72 as a novel biomarker to detect AKI, EMBO Mol Med, 3, 5, 10.1002/emmm.201000105 · DOI
- Mishra, 2005, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, Lancet, 365, 1231, 10.1016/S0140-6736(05)74811-X · DOI · Paper page
- Morales-Buenrostro, 2014, Hsp72 is a novel biomarker to predict acute kidney injury in critically Ill patients, PLoS ONE, 9, e109407, 10.1371/journal.pone.0109407 · DOI
- Zhou, 2006, Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury, Kidney Int, 70, 1847, 10.1038/sj.ki.5001874 · DOI · Paper page
- Lennon, 2014, The importance of podocyte adhesion for a healthy glomerulus, Front Endocrinol, 5, 160, 10.3389/fendo.2014.00160 · DOI
- Suzuki, 2011, The Pathophysiology of IgA Nephropathy, J Am Soc Nephrol, 22, 1795, 10.1681/ASN.2011050464 · DOI · Paper page
- Churg, 1995, Renal Disease: Classification and Atlas of Glomerular Disease
- Tryggvason, 2006, Thin basement membrane nephropathy, J Am Soc Nephrol, 17, 813, 10.1681/ASN.2005070737 · doi:10.1681/asn.2005070737
- Hartung, 2014, Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects, Pediatrics, 134, e833, 10.1542/peds.2013-3646 · DOI · Paper page
- Nogueira, 2010, Other biomarkers for detecting prostate cancer, BJU Int, 105, 166, 10.1111/j.1464-410X.2009.09088.x · doi:10.1111/j.1464-410x.2009.09088.x
- Hessvik, 2013, Exosomal miRNAs as biomarkers for prostate cancer, Front Genet, 4, 36, 10.3389/fgene.2013.00036 · DOI
- Théry, 2009, Membrane vesicles as conveyors of immune responses, Nat Rev Immunol, 9, 581, 10.1038/nri2567 · DOI · Paper page
- Cantaluppi, 2012, Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells, Kidney Int, 82, 412, 10.1038/ki.2012.105 · DOI · Paper page
- Bitzer, 2012, Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury, Kidney Int, 82, 375, 10.1038/ki.2012.152 · doi:10.1038/ki.2012.152
- Chen, 2014, Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion, J Cell Physiol, 229, 1202, 10.1002/jcp.24554 · DOI
- Sanchez, 2014, Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury, Stem Cell Res Ther, 5, 124, 10.1186/scrt514 · DOI
Cited by
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
A proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348
Isolation of Extracellular Vesicles: General Methodologies and Latest Trends
Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V., & Laktionov, P. P. (2018) · BioMed Research International · doi:10.1155/2018/8545347 · Cited by 1,243
Gámez-Valero, A., Monguió-Tortajada, M., Carreras-Planella, L., Franquesa, M., Beyer, K., & Borràs, F. E. (2016) · Scientific Reports · doi:10.1038/srep33641 · Cited by 594
Self-citationEvidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
Fais, S., O’Driscoll, L., Borras, F. E., Buzas, E., Camussi, G., Cappello, F., Carvalho, J., Cordeiro da Silva, A., Del Portillo, H., El Andaloussi, S., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b08015 · Cited by 481
Metadata
- Authors
- Gámez-Valero, A., Lozano-Ramos, S. I., Bancu, I., Lauzurica-Valdemoros, R., & Borrà s, F. E.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-01-30
- Volume
- 6
- Pages
- 6-6
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2126856293
- Cited by
- 143
- References
- 10
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases. https://app.cochat.ai/papers/10.3389/fimmu.2015.00006
- The paper
- Gámez-Valero, A., Lozano-Ramos, S. I., Bancu, I., Lauzurica-Valdemoros, R., & Borrà s, F. E. (2015). Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2015.00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.